NS-49, an α(1A)-adrenoceptor agonist, selectively increases intraurethral pressure in dogs

European Journal of Pharmacology

Volumn 318, Issue 1, 1996, Pages 117-122

  Taniguchi, Norihisa ^a   Hamada, Kozo ^a   Ogasawara, Takashi ^a   Ukai, Yojiro ^a   Yoshikuni, Yoshiaki ^a   Kimura, Kiyoshi ^a  

^a NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

1 Adrenoceptor, subtype; Blood pressure; Intraurethral pressure; NS 49

Indexed keywords

2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 2 AMINO 1 (2,5 DIMETHOXYPHENYL)ETHANOL; 3' (2 AMINO 1 HYDROXYETHYL) 4' FLUOROMETHANESULFONANILIDE; 5 METHYLURAPIDIL; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CAROTID ARTERY; CONTROLLED STUDY; DOG; DRUG RECEPTOR BINDING; FEMALE; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; STRESS INCONTINENCE; SUBMANDIBULAR GLAND; URETHRA; URETHRA PRESSURE;

ADRENERGIC ALPHA-AGONISTS; ANILIDES; ANIMALS; BLOOD PRESSURE; CAROTID ARTERIES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LIVER; MALE; MIDODRINE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; MUSCLE, SMOOTH, VASCULAR; PRAZOSIN; PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; SUBMANDIBULAR GLAND; URETHRA;

EID: 0030604291     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00766-2     Document Type: Article

References (21)

1. Bylund, D.B., D.C. Eikenburg, J.P. Hieble, S.Z. Langer, R.J. Lefkowitz, K.P. Minneman, P.B. Molinoff, R.R. Ruffolo Jr. and U. Trendelenburg, 1994, International Union of Pharmacology nomenclature of adrenoceptors, Pharmacol. Rev. 46, 121.
2. Ek, A., K.-E. Andersson, B. Gullberg and U. Ulmsten, 1978, The effects of long-term treatment with norephedrine on stress incontinence and urethral closure pressure profile, Scand. J. Urol. Nephrol. 12, 105.
3. 1-Adrenoceptor classification: sharpening Occam's razor, Trends Pharmacol. Sci. 15, 167.
4. 1-adrenoceptors in human prostate: implication for adrenoceptor classification, Mol. Pharmacol. 49, 209.
5. 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery, Br. J. Pharmacol. 113, 723.
6. 1-adrenoceptors: consensus update, Pharmacol. Rev. 47, 267.
7. Jonas, D., 1977, Treatment of female stress incontinence: preliminary report, J. Urol. 118, 980.
8. 1-blocker, YM617, in the treatment of benign prostatic hypertrophy, J. Urol. 144, 908.
9. Kawabe, K., N. Moriyama, S. Yamada and N. Taniguchi, 1994, Rationale for alpha-blockers in the treatment of benign prostatic hyperplasia (BPH), Int. J. Urol. 1, 203.
10. Kontani, H., M. Nakagawa and T. Sakai, 1992, Effects of adrenergic agonists on experimental urinary incontinence model in anesthetized rabbits, Jpn. J. Pharmacol. 58, 339.
11. 1-adrenoceptor subtypes, Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 136.
12. 1A-subtype in rat submaxillary gland, Br. J. Pharmacol. 98, 883.
13. 1-adrenoceptor subtypes, Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 2.
14. Nito, H., 1994, Clinical effect of midodrine hydrochloride on the patients with urinary incontinence, Acta Urol. Jpn. 40, 91.
15. 1-adrenoceptors, Eur. J. Pharmacol. 291, 327.
16. Öbrink, A. and G. Bunne, 1978, The effects of alpha-adrenergic stimulation in stress incontinence, Scand. J. Urol. Nephrol. 12, 205.
17. 1-adrenergic physiology, Mol. Pharmacol. 45, 171.
18. Raz, S. and M. Caine, 1972, Adrenergic receptors in the female canine urethra, Invest. Urol. 9, 319.
19. 1-Adrenoceptors: recent development, Med. Res. Rev. 14, 229.
20. 1-adrenoceptor agonist on the bladder and urethra of female dogs, Jpn. J. Urol. 82, 1292.
21. 1C, Biochem. Biophys. Res. Commun. 201, 1296.